Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MRSA Rapidly Detected in Mixed Samples

By HospiMedica staff writers
Posted on 20 Dec 2006
A new kit rapidly detects methicillin-resistant Staphylococcus aureus (MRSA) even in cases of mixed colonization.

The GenoQuick MRSA kit utilizes MRSA-specific DNA sequences in the Staphylococcal cassette chromosome (SSCmec types 1-V) to enable direct testing without the need for time-consuming culture. More...
A simple dipstick procedure accelerates the detection process with results being generated as an obvious banding pattern on the membrane strips. The presence of both amplification and conjugate controls gives the user confidence in reporting the presence of MRSA from a patient specimen to a sensitivity of 10-15 colony forming units (cfu). No elaborate equipment is required, and the test can easily be incorporated into a routine diagnostic laboratory. The kit is available in either 12 test or 48 test formats, making it suitable for both small volume users and high throughput laboratories.

To ensure valid results, each sample is co-analyzed with an amplification control, which reliably indicates potential inhibition. It identifies a MRSA-specific fragment not present in methicillin-sensitive S aureus (MSSA) or in coagulase-negative staphylococci. Therefore, no pure culture is required and the material can be directly analyzed from the swab.

Supplied by Hain Lifescience (Nehren, Germany), the GenoQuick MRSA assay is user-friendly. Colored solutions prevent pipetting errors, and the simple detection technique largely reduces pipetting effort. Test results from direct samples are available within only 2.5 hr. The test has received the CE Mark.

One of the most important benefits for labs of all sizes is the reduced need for equipment. Initial costs are therefore considerably lower compared to other MRSA assay systems.



Related Links:
Hain Lifescience

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.